Network News

One device – two organs: Simultaneous perfusion opens up new possibilities for future multi-organ transplants

One device – two organs: Simultaneous perfusion opens up new possibilities for future multi-organ transplants

Award-winning: Concept for “the perfect stroke room”

Award-winning: Concept for “the perfect stroke room”

FDA approves Promega OncoMate® MSI Dx Analysis System as a companion diagnostic for KEYTRUDA® in combination with LENVIMA® in advanced endometrial cancer

FDA approves Promega OncoMate® MSI Dx Analysis System as a companion diagnostic for KEYTRUDA® in combination with LENVIMA® in advanced endometrial cancer

AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma

Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg with 16 “Highly Cited Researchers”

Universität Heidelberg: New DFG Research Unit in Oncology

Universität Heidelberg: New DFG Research Unit in Oncology

Phylogenetic trees, biodiversity and research policy: “Highly Cited Researcher“ at HITS

Phylogenetic trees, biodiversity and research policy: “Highly Cited Researcher“ at HITS

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

How the biological clock ticks in the female reproductive tract – Breakthrough of the Year Award 2025 for Ângela Gonçalves

How the biological clock ticks in the female reproductive tract – Breakthrough of the Year Award 2025 for Ângela Gonçalves